Found 1 Presentation For Request "claridhy"

Proffered Paper session Proffered Paper session

LBA10_PR - ClarIDHy: A global, phase 3, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation (ID 1867)

Presentation Number
LBA10_PR
Lecture Time
16:30 - 16:42
Speakers
  • Ghassan K. Abou-Alfa (New York, NY, United States of America)
Location
Barcelona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:15